©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 111414
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111414
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.111414
Figure 2 Changes of lipid profile during hospitalization.
The patient had persistent hyperlipidemia during the entire observational period. Her lipid levels all remained at levels above 10 times higher than normal after receiving glucocorticosteroids. TC: Total cholesterol; TG: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol.
- Citation: Xu MJ, Wei X, Lu Y, Sun L, Xie Y, Li MH. Severe hyperlipidemia associated with drug-induced cholestatic liver disease: A case report. World J Hepatol 2025; 17(12): 111414
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/111414.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.111414